Only 6% of trials for FDA-approved drugs match America's diversity. Analysis reveals how trial location and design choices ...
Thursday, the FDA addressed the shortfall with a label expansion for GSK’s Blujepa, which brings an oral option and a new ...
Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli ...
The FDA has cleared the use of GSK’s Blujepa for the treatment of uncomplicated urogenital gonorrhea, unlocking the first new ...
MedPage Today on MSN
RFK Jr.’s Former Group Urges FDA to Revoke COVID Vax Licenses
An anti-vaccine organization founded by HHS Secretary Robert F. Kennedy Jr. is urging the FDA he now oversees to pull the ...
The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans.
FDA may expedite approval timeline for Eli Lilly's weight-loss treatment, potentially moving decision date to late March from ...
The FDA is planning its strongest safety alert for Covid-19 vaccines as debates over risks, including myocarditis in young ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
NEWS RELEASE: ten23 health QC lab to support commercial product testing for U.S. customer following FDA approvals Basel, ...
MedPage Today on MSN
Novel Oral Antibiotic Matches Standard Option for Urogenital Gonorrhea
"Considering the urgent global need for new gonorrhea treatments, the finding that a single-dose of oral zoliflodacin was efficacious at curing urogenital and rectal and pharyngeal gonorrhoea is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results